• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国临床内分泌医师协会和美国内分泌学会关于自主神经和躯体神经功能障碍检测的立场声明

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.

作者信息

Vinik Aaron I, Camacho Pauline M, Davidson Jaime A, Handelsman Yehuda, Lando Howard M, Leddy Anne L, Reddy Sethu K, Cook Richard, Spallone Vicenza, Tesfaye Solomon, Ziegler Dan

出版信息

Endocr Pract. 2017 Dec;23(12):1472-1478. doi: 10.4158/EP-2017-0053.

DOI:10.4158/EP-2017-0053
PMID:29320641
Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

摘要

本文件代表了美国临床内分泌医师协会和美国内分泌学会的官方立场。对于临床实践中没有随机对照试验或美国食品药品监督管理局(FDA)特定标签的问题,参与的临床专家运用了他们的判断和经验。已尽一切努力在委员会成员之间达成共识。立场声明旨在提供指导,但不应被视为对任何个体患者具有规定性,也不能取代临床医生的判断。

相似文献

1
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.美国临床内分泌医师协会和美国内分泌学会关于自主神经和躯体神经功能障碍检测的立场声明
Endocr Pract. 2017 Dec;23(12):1472-1478. doi: 10.4158/EP-2017-0053.
2
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.美国临床内分泌医师协会和美国内分泌学会 2018 年关于糖尿病患者胰岛素泵和连续血糖监测整合的立场声明。
Endocr Pract. 2018 Mar;24(3):302-308. doi: 10.4158/PS-2017-0155.
3
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK.美国临床内分泌医师协会与美国内分泌学会关于睾酮与心血管风险关联的立场声明
Endocr Pract. 2015 Sep;21(9):1066-73. doi: 10.4158/EP14434.PS.
4
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会关于2型糖尿病综合管理算法的共识声明——2015年执行摘要
Endocr Pract. 2015 Dec;21(12):1403-14. doi: 10.4158/EP151063.CS.
5
Proceedings from the American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on glucose monitoring.美国临床内分泌医师协会和美国内分泌学会关于血糖监测的共识会议纪要。
Endocr Pract. 2015 May;21(5):522-33. doi: 10.4158/EP15653.CS.
6
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT.美国临床内分泌医师协会和美国内分泌学会2016年门诊血糖监测共识声明
Endocr Pract. 2016 Feb;22(2):231-61. doi: 10.4158/EP151124.CS. Epub 2016 Jan 27.
7
AACE/ACE POSITION STATEMENT ON THE USE OF FOLLOW-ON BIOLOGICS AND BIOSIMILARS FOR ENDOCRINE DISEASES.美国临床内分泌医师协会/美国内分泌学会关于后续生物制品和生物类似药用于内分泌疾病的立场声明。
Endocr Pract. 2017 Nov;23(11):1345-1349. doi: 10.4158/EP-2017-0052.
8
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY.美国临床内分泌医师协会和美国内分泌学会血脂异常管理和心血管疾病预防指南 - 执行摘要。
Endocr Pract. 2017 Apr 2;23(4):479-497. doi: 10.4158/EP171764.GL. Epub 2017 Feb 3.
9
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE QUALITY OF DXA SCANS AND REPORTS.美国临床内分泌医师协会和美国内分泌学会关于 DXA 扫描和报告质量的共识声明
Endocr Pract. 2018 Feb;24(2):220-229. doi: 10.4158/CS-2017-0081.
10
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: UPDATE ON GROWTH HORMONE STIMULATION TESTING AND PROPOSED REVISED CUT-POINT FOR THE GLUCAGON STIMULATION TEST IN THE DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY.美国临床内分泌医师协会和美国内分泌学会疾病临床评论:生长激素刺激试验的更新和诊断成人生长激素缺乏症时葡萄糖刺激试验拟议的新切点。
Endocr Pract. 2016 Oct;22(10):1235-1244. doi: 10.4158/EP161407.DSCR. Epub 2016 Jul 13.

引用本文的文献

1
An automated human-machine interaction system enhances standardization, accuracy and efficiency in cardiovascular autonomic evaluation: A multicenter, open-label, paired design study.一种自动化人机交互系统提高了心血管自主神经评估的标准化、准确性和效率:一项多中心、开放标签、配对设计研究。
J Transl Int Med. 2025 May 8;13(2):170-179. doi: 10.1515/jtim-2025-0013. eCollection 2025 Apr.
2
Cardiovascular autonomic neuropathy in diabetes: an update with a focus on management.糖尿病性心血管自主神经病变:更新与管理重点
Diabetologia. 2024 Dec;67(12):2611-2625. doi: 10.1007/s00125-024-06242-0. Epub 2024 Aug 9.
3
Associations of age-adjusted coefficient of variation of R-R intervals with autonomic and peripheral nerve function in non-elderly persons with diabetes.
非老年糖尿病患者 R-R 间期校正后变异系数与自主神经和周围神经功能的相关性。
J Diabetes Investig. 2024 Feb;15(2):186-196. doi: 10.1111/jdi.14094. Epub 2023 Oct 16.
4
Mortality risk factors in newly diagnosed diabetic cardiac autonomic neuropathy.新诊断糖尿病性心脏自主神经病变的死亡风险因素
Clin Auton Res. 2023 Dec;33(6):903-907. doi: 10.1007/s10286-023-00975-5. Epub 2023 Sep 11.
5
Dapagliflozin Improves Cardiac Autonomic Function Measures in Type 2 Diabetic Patients with Cardiac Autonomic Neuropathy.达格列净改善伴有心脏自主神经病变的 2 型糖尿病患者的心脏自主神经功能指标。
Anatol J Cardiol. 2022 Nov;26(11):832-840. doi: 10.5152/AnatolJCardiol.2022.1934.
6
Dysautonomia: A Forgotten Condition - Part II.自主神经功能障碍:一种被遗忘的病症 - 第二部分。
Arq Bras Cardiol. 2021 May;116(5):981-998. doi: 10.36660/abc.20200422.
7
Dysautonomia: A Forgotten Condition - Part 1.自主神经功能紊乱:一种被遗忘的疾病 - 第 1 部分。
Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420.
8
Clinical spectrum and diagnosis of diabetic neuropathies.糖尿病神经病变的临床特征和诊断。
Korean J Intern Med. 2020 Sep;35(5):1059-1069. doi: 10.3904/kjim.2020.202. Epub 2020 Aug 28.
9
Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.糖尿病心脏自主神经病变的影响、诊断和管理的最新进展:定义了什么,有什么新内容,以及有哪些尚未满足的需求。
Diabetes Metab J. 2019 Feb;43(1):3-30. doi: 10.4093/dmj.2018.0259.